Results 1 to 10 of about 358,151 (371)

CAR-T Cells in the Treatment of Urologic Neoplasms: Present and Future [PDF]

Frontiers in Oncology, 2022
In recent years, with the breakthrough of CAR-T cells in the treatment of hematological tumors, they are increasingly being used to treat solid tumors, including urologic neoplasms.
Zhengchao Zhang, Zhengchao Zhang, Dong Li, Heng Yun, Wei Liu, Keqiang Chai, Jie Tong, Tongwei Zeng, Zhenghua Gao, Yongqiang Xie   +9 more
doaj   +7 more sources

Targeting c-Met in the treatment of urologic neoplasms: Current status and challenges [PDF]

Frontiers in Oncology, 2023
At present, studies have found that c-Met is mainly involved in epithelial-mesenchymal transition (EMT) of tumor tissues in urologic neoplasms. Hepatocyte growth factor (HGF) combined with c-Met promotes the mitosis of tumor cells, and then induces ...
Pengxiao Su, Ming Zhang, Xin Kang
doaj   +7 more sources

Acceptance of emerging renal oncocytic neoplasms: a survey of urologic pathologists. [PDF]

Virchows Arch
Oncocytic renal neoplasms are a major source of diagnostic challenge in genitourinary pathology; however, they are typically nonaggressive in general, raising the question of whether distinguishing different subtypes, including emerging entities, is ...
Mohanty SK, Lobo A, Jha S, Sangoi AR, Akgul M, Trpkov K, Hes O, Mehra R, Hirsch MS, Moch H, Smith SC, Shah RB, Cheng L, Amin MB, Epstein JI, Parwani AV, Delahunt B, Desai S, Przybycin CG, Manini C, Luthringer DJ, Sirohi D, Jain D, Midha D, Jain E, Maclean F, Giannico GA, Paner GP, Martignoni G, Al-Ahmadie HA, McKenney J, Srigley JR, Lopez JI, Kunju LP, Browning L, Aron M, Picken MM, Tretiakova M, Zhou M, Sable M, Kuroda N, Pattnaik N, Gupta NS, Rao P, Fine SW, Mishra P, Adhya AK, Kulkarni BN, Dixit M, Baisakh MR, Arora S, Sancheti S, Menon S, Wobker SE, Tickoo SK, Kaushal S, Soni S, Kandukuri S, Sharma S, Mitra S, Reuter VE, Malik V, Rao V, Chen YB, Williamson SR.   +64 more
europepmc   +8 more sources

Microbiome in urologic neoplasms: focusing on tumor immunity [PDF]

Frontiers in Immunology
Urological tumors are an important disease affecting global human health, and their pathogenesis and treatment have been the focus of medical research.
Jun Zou, Baisheng Xu, Hongbing Gao, Peiyue Luo, Tao Chen, Huanglin Duan   +5 more
doaj   +4 more sources

Updates in Histologic Grading of Urologic Neoplasms. [PDF]

Archives of Pathology & Laboratory Medicine, 2020
CONTEXT.— Tumor histology offers a composite view of the genetic, epigenetic, proteomic, and microenvironmental determinants of tumor biology. As a marker of tumor histology, histologic grading has persisted as a highly relevant factor in risk ...
Travis L. Rice-Stitt, Aida Valencia-Guerrero, K. Cornejo, Chin-Lee Wu   +3 more
semanticscholar   +5 more sources

Diagnostic criteria for oncocytic renal neoplasms: a survey of urologic pathologists. [PDF]

Human Pathology, 2017
Renal oncocytoma and chromophobe renal cell carcinoma have been long recognized as distinct tumors; however, it remains unknown if uniform diagnostic criteria are used to distinguish these tumor types in practice. A survey was distributed to urologic pathologists regarding oncocytic tumors. Responses were received from 17 of 26 invitees. Histologically,
S. Williamson, S. Williamson, R. Gadde, K. Trpkov, M. Hirsch, J. Srigley, V. Reuter, Liang Cheng, L. Kunju, R. Barod, C. Rogers, B. Delahunt, O. Hes, J. Eble, Ming Zhou, J. McKenney, G. Martignoni, S. Fleming, D. Grignon, H. Moch, N. Gupta   +20 more
semanticscholar   +7 more sources

The expression of apolipoproteina1 and its correlation with infiltration of urologic neoplasm [PDF]

Translational Cancer Research, 2020
To explore the differential expression of apolipoproteinA1 (APOA1) in urologic neoplasm patient compared with controls, as well as investigates whether APOA1 correlated with infiltration of urologic neoplasm.A total of 59 tissue sections of surgically-resected urologic neoplasm and 6 cases of normal tissue sections were collected.
Huihui Hu, Bei Gong, Man Zhang
openalex   +4 more sources

The Role of Exenterative Surgery in Advanced Urological Neoplasms

Current Urology, 2020
Pelvic exenterative surgery is both complex and challenging, especially in the setting of locally recurrent disease. In recent decades, improved surgical techniques have facilitated more extensive resection of both locally advanced and recurrent pelvic malignancies, but its role in urological cancer surgery is highly selective.
Colla Cunneen, Michael E. Kelly, Gregory J. Nason, Éanna J. Ryan, Ben Creavin, D. C. Winter   +5 more
openalex   +4 more sources

Operations for Urologic Malignant Tumors or Suspected Neoplasms in a Resource-Limited Setting: Last Decade Experience in Cameroon

Cancer Science & Research, 2019
Within the framework of the treatment of cancer, surgery plays a key role. Urological cancer incidence is increasing and will become a more serious issue in the future.
Djeumi T, Guifo Ml, M. A
semanticscholar   +2 more sources

Comprehensive Review of Genetic Association Studies and Meta-Analysis on polymorphisms in microRNAs and Urological Neoplasms Risk [PDF]

Scientific Reports, 2018
AbstractGene expression is negatively regulated by microRNAs (miRNAs), which commonly act as tumor oncogenes or suppressors. Previous results were inconsistent concerning the relationship between polymorphisms in miRNAs and risk of urological neoplasms.
Ligang Zhang, Meng Zhang, Hao Wang, Yangyang Wang, Jun Zhou, Zongyao Hao, Li Zhang, Chaozhao Liang   +7 more
openalex   +4 more sources